期刊文献+

祛斑养阴颗粒剂对系统性红斑狼疮的生存质量的影响

Observation of Qubanyangyin granules on quality of life in systemic lupus erythematosus patients
下载PDF
导出
摘要 目的观察祛斑养阴颗粒剂对系统性红斑狼疮(SLE)患者生存质量(QOL)的影响。方法将80例SLE患者随机分为2组。中西药组40例予祛斑养阴颗粒剂和西药常规方案治疗,西药组40例予西药常规方案治疗,在入组时即对患者进行健康状况调查问卷(SF-36)调查,治疗后观察病情改善状况、SF-36 QOL问卷调查和中医证候积分,对2组QOL方面及中医证候的改善情况进行分析。结果 2组治疗前经SF-36调查测定后,8个QOL维度的评分及综合评分经统计学检验,治疗前QOL评分比较差异均无统计学意义(P>0.05),具有可比性。中西药组治疗后各维度QOL评分及综合评分均较本组治疗前上升(P<0.05);西药组治疗后各维度QOL评分及综合评分均较本组治疗前上升,其中躯体角色(RP)、精力(VT)、心理健康(MH 3)个维度QOL评分有统计学意义(P<0.05)。中西药组治疗后各维度QOL评分及综合评分高于西药组(P<0.05)。结论祛斑养阴颗粒剂结合西药能更有效的治疗SLE,改善患者症状,提高患者QOL。 Objective To observe changes in quality of life in systemic lupus erythematosus(SLE) patients treated with Qubanyangyin granules.Methods The outpatient and inpatient clinical diagnosis of systemic lupus erythematosus with a total of 80 patients were randomly divided into integrated traditional Chinese and western medicine group(40 cases),which was treated by Qubanyangyin granules and conventional western medicine,western medicine group(n=40),which was treated by conventional western medicine.SF-36 of all cases was administered before incorporating group.After treatment for 3 months the improvement of the situation and its SF-36 questionnaires including patients on physical function,vitality,social function,etc.all in the quality of life and scoring points of traditional Chinese medicine(TCM) syndromes were observed and compared.Results The dimensions of quality of life scores and total scores are rising after treatment in integrated traditional Chinese and western medicine group,the self-paired t test was significant(P0.05).Quality of life dimension scores and total scores are rising in western medicine group,including the role-physical,vitality and mental health in three dimensions and total score paired t test by itself was significant(P0.05).The dimensions of quality of life scores and total scores in integrated traditional Chinese and western medicine group was higher than that in western medicine group after treatment(P0.05).Conclusion The combination of Qubanyangyin granules and western medicine has more effective treatment on systemic lupus erythematosus,and can improve symptoms and quality of life of patients.
出处 《河北中医》 2011年第7期979-981,共3页 Hebei Journal of Traditional Chinese Medicine
基金 广东省深圳市第3批重点医学专科(实验室)(编号:2005C10) 国家"十一五"科技支撑计划课题(编号:2008BAI59B02)
关键词 红斑狼疮 系统性 中药疗法 剂型 Lupus erythematosus Systemic Traditional Chinese drug therapeutics Formulation
  • 相关文献

参考文献10

  • 1刘朝杰,李宁秀,任晓晖,李俊,张骏,孙丁.36条目简明量表在中国人群中的适用性研究[J].华西医科大学学报,2001,32(1):39-42. 被引量:311
  • 2李春波,何燕玲.健康状况调查问卷SF-36的介绍[J].国外医学(精神病学分册),2002,29(2):116-119. 被引量:580
  • 3Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythema- tosus [ J ]. Arthritis Rheum, 1997,40 ( 9 ) : 1725.
  • 4Gladman DD, Iba ez D, Urowitz MB. Systemic lupus erythema- tosus disease activity index 2000 [ J ]. J Rheumatol, 2002,29 (2) :288 -291.
  • 5谭小波,邓小玲,叶亚丽.静脉环磷酰胺冲击治疗狼疮肾炎患者生存质量调查分析[J].华西医学,2009,24(5):1270-1272. 被引量:1
  • 6许军,胡敏燕,杨云滨,王斌会,解亚宁.健康测量量表SF-36[J].中国行为医学科学,1999,8(2):150-152. 被引量:454
  • 7Shaun Ruddy,M.d.凯利风湿病学[M].左晓霞,陶立坚,高洁生,主译.北京:人民卫生出版社,2002:347.
  • 8钟连生,马道铭,陈志强.糖皮质激素受体研究进展[J].国外医学(皮肤性病学分册),2005,31(4):199-201. 被引量:14
  • 9Strand V, Aranow C, Cardiel MH, et al. Improvement in health - related quality of life in systemic lupus erythematosus patients enrolled in a randomized clinical trial comparing LJP 394 treat- ment with placebo[ J ]. Lupus ,2003,12 (9) :677 - 686.
  • 10Rood MJ, BorggTeve SE, Huizinga TW. Sensitivity to change of the MOS SF - 36 quality of life assessment questionnaire in patients with systemic lupus erythematosus taking immunosup- pressive therapy [ J ]. J Rheumatol, 2000, 27 ( 8 ) : 2057 - 2059.

二级参考文献29

  • 1舒强,刘静,刘花香,李兴福.系统性红斑狼疮患者151例的生存质量及其影响因素[J].中华风湿病学杂志,2004,8(7):420-423. 被引量:25
  • 2刘静,舒强,王洁贞.用SF-36量表评价红斑狼疮患者生存质量[J].中国公共卫生,2004,20(11):1383-1384. 被引量:16
  • 3陈和年.生存质量测量的方法学研究及其应用[J].中国学术期刊文献,1996,2(7):114-114.
  • 4AUSTIN HA Ⅲ,KLIPPEL J H,BALOW J E, et al. Therapy of lupus nephritis:controlled trail of prerdnisone and cytotoxic drugs[J]. N Engl J Meal,1998,314:614-619.
  • 5STOLL T, GORDON C, SEIFERTB. Consistency and validity of patient administered assessment of quality of life by the MOS SF-36;its association with disease activity and damage in patientswith systemic lupus erythematosus[J].J RheumatoI, 1997, 24: 1608-1614.
  • 6THUMBOO J. Validation of the Mos sf-36for quality of life assessment of patients with systemic lupus erythematosus in Singapore[J]. J Rheumatol,1999,26(1) ~97-102.
  • 7SUTCLIFFE N. Associates of health status in patients with systemic lupus erythematosus[J]. J Rheumatol, 1999, 26 ( 1 ) 2352-2356.
  • 8许军,国外医学.社会医学分册,1998年,15卷,3期,105页
  • 9魏朝晖,国外医学.社会医学分册,1997年,14卷,4期,145页
  • 10陈和年,中国学术期刊文摘,1996年,2卷,7期,114页

共引文献1319

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部